APO Research

APO RESEARCH · REPORT

Cannabinoid Profiling

Selected research

Market Analysis & Forecast

Global Cannabinoid Profiling Market Analysis and Forecast 2026-2032

Market perspective

The global Cannabinoid Profiling market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cannabinoid Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cannabinoid Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cannabinoid Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cannabinoid Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cannabinoid Profiling include Saskatchewan Research Council (SRC), SC Labs, Steep Hill, SGS Canada, CW ANALYTICAL, PharmLabs, GreenLeaf Lab, Kaycha Holdings and American Clinical Solutions, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cannabinoid Profiling, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cannabinoid Profiling, also provides the revenue of main regions and countries. Of the upcoming market potential for Cannabinoid Profiling, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cannabinoid Profiling revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cannabinoid Profiling market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cannabinoid Profiling revenue, projected growth trends, production technology, application and end-user industry.

Cannabinoid Profiling Segment by Company

Saskatchewan Research Council (SRC)

SC Labs

Steep Hill

SGS Canada

CW ANALYTICAL

PharmLabs

GreenLeaf Lab

Kaycha Holdings

American Clinical Solutions

CannaSafe

Aurum Labs

A&L Canada Laboratories

Royalmount Laboratories

Confidence Analytics

ACT Laboratories

Cannabinoid Profiling Segment by Type

Gas Chromatography

Liquid Chromatography

Cannabinoid Profiling Segment by Application

Cannabis Drug Manufacturers

Cannabis Cultivators/Growers

Research Institutes

Others

Cannabinoid Profiling Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabinoid Profiling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cannabinoid Profiling and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabinoid Profiling.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cannabinoid Profiling in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cannabinoid Profiling company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cannabinoid Profiling revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cannabinoid Profiling Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gas Chromatography Major Player Table 3. Liquid Chromatography Major Player Table 4. Global Cannabinoid Profiling Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cannabis Drug Manufacturers Major Player Table 6. Cannabis Cultivators/Growers Major Player Table 7. Research Institutes Major Player Table 8. Others Major Player Table 9. Cannabinoid Profiling Industry Trends Table 10. Cannabinoid Profiling Industry Drivers Table 11. Cannabinoid Profiling Industry Opportunities and Challenges Table 12. Cannabinoid Profiling Industry Restraints Table 13. Global Cannabinoid Profiling Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cannabinoid Profiling Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cannabinoid Profiling Market Share by Region (2021-2026) Table 16. Global Cannabinoid Profiling Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cannabinoid Profiling Market Share by Region (2027-2032) Table 18. Global Cannabinoid Profiling Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cannabinoid Profiling Revenue Market Share by Players (2021-2026) Table 20. Global Cannabinoid Profiling Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cannabinoid Profiling Key Players Headquarters & Area Served Table 22. Global Cannabinoid Profiling Players, Product Type & Application Table 23. Global Cannabinoid Profiling Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cannabinoid Profiling by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cannabinoid Profiling Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cannabinoid Profiling Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cannabinoid Profiling Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cannabinoid Profiling Revenue Market Share by Type (2021-2026) Table 30. Global Cannabinoid Profiling Revenue Market Share by Type (2027-2032) Table 31. Global Cannabinoid Profiling Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cannabinoid Profiling Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cannabinoid Profiling Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cannabinoid Profiling Revenue Market Share by Application (2021-2026) Table 35. Global Cannabinoid Profiling Revenue Market Share by Application (2027-2032) Table 36. Saskatchewan Research Council (SRC) Company Information Table 37. Saskatchewan Research Council (SRC) Business Overview Table 38. Saskatchewan Research Council (SRC) Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Saskatchewan Research Council (SRC) Cannabinoid Profiling Product Portfolio Table 40. Saskatchewan Research Council (SRC) Recent Development Table 41. SC Labs Company Information Table 42. SC Labs Business Overview Table 43. SC Labs Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. SC Labs Cannabinoid Profiling Product Portfolio Table 45. SC Labs Recent Development Table 46. Steep Hill Company Information Table 47. Steep Hill Business Overview Table 48. Steep Hill Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Steep Hill Cannabinoid Profiling Product Portfolio Table 50. Steep Hill Recent Development Table 51. SGS Canada Company Information Table 52. SGS Canada Business Overview Table 53. SGS Canada Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. SGS Canada Cannabinoid Profiling Product Portfolio Table 55. SGS Canada Recent Development Table 56. CW ANALYTICAL Company Information Table 57. CW ANALYTICAL Business Overview Table 58. CW ANALYTICAL Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. CW ANALYTICAL Cannabinoid Profiling Product Portfolio Table 60. CW ANALYTICAL Recent Development Table 61. PharmLabs Company Information Table 62. PharmLabs Business Overview Table 63. PharmLabs Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. PharmLabs Cannabinoid Profiling Product Portfolio Table 65. PharmLabs Recent Development Table 66. GreenLeaf Lab Company Information Table 67. GreenLeaf Lab Business Overview Table 68. GreenLeaf Lab Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. GreenLeaf Lab Cannabinoid Profiling Product Portfolio Table 70. GreenLeaf Lab Recent Development Table 71. Kaycha Holdings Company Information Table 72. Kaycha Holdings Business Overview Table 73. Kaycha Holdings Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Kaycha Holdings Cannabinoid Profiling Product Portfolio Table 75. Kaycha Holdings Recent Development Table 76. American Clinical Solutions Company Information Table 77. American Clinical Solutions Business Overview Table 78. American Clinical Solutions Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. American Clinical Solutions Cannabinoid Profiling Product Portfolio Table 80. American Clinical Solutions Recent Development Table 81. CannaSafe Company Information Table 82. CannaSafe Business Overview Table 83. CannaSafe Cannabinoid Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. CannaSafe Cannabinoid Profiling Product Portfolio Table 85. CannaSafe Recent Development Table 86. Aurum Labs Company Information Table 87. Aurum Labs Business Overview Table 88. Aurum Labs Cannabinoid Profiling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Aurum Labs Cannabinoid Profiling Product Portfolio Table 90. Aurum Labs Recent Development Table 91. A&L Canada Laboratories Company Information Table 92. A&L Canada Laboratories Business Overview Table 93. A&L Canada Laboratories Cannabinoid Profiling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. A&L Canada Laboratories Cannabinoid Profiling Product Portfolio Table 95. A&L Canada Laboratories Recent Development Table 96. Royalmount Laboratories Company Information Table 97. Royalmount Laboratories Business Overview Table 98. Royalmount Laboratories Cannabinoid Profiling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Royalmount Laboratories Cannabinoid Profiling Product Portfolio Table 100. Royalmount Laboratories Recent Development Table 101. Confidence Analytics Company Information Table 102. Confidence Analytics Business Overview Table 103. Confidence Analytics Cannabinoid Profiling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Confidence Analytics Cannabinoid Profiling Product Portfolio Table 105. Confidence Analytics Recent Development Table 106. ACT Laboratories Company Information Table 107. ACT Laboratories Business Overview Table 108. ACT Laboratories Cannabinoid Profiling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. ACT Laboratories Cannabinoid Profiling Product Portfolio Table 110. ACT Laboratories Recent Development Table 111. North America Cannabinoid Profiling Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Cannabinoid Profiling Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Cannabinoid Profiling Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Cannabinoid Profiling Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Cannabinoid Profiling Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Cannabinoid Profiling Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Cannabinoid Profiling Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Cannabinoid Profiling Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Cannabinoid Profiling Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Cannabinoid Profiling Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Cannabinoid Profiling Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Cannabinoid Profiling Revenue by Country (US$ Million) & (2027-2032) Table 125. China Cannabinoid Profiling Revenue by Type (2021-2026) & (US$ Million) Table 126. China Cannabinoid Profiling Revenue by Type (2027-2032) & (US$ Million) Table 127. China Cannabinoid Profiling Revenue by Application (2021-2026) & (US$ Million) Table 128. China Cannabinoid Profiling Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Cannabinoid Profiling Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Cannabinoid Profiling Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Cannabinoid Profiling Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Cannabinoid Profiling Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Cannabinoid Profiling Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Cannabinoid Profiling Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Cannabinoid Profiling Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Cannabinoid Profiling Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Cannabinoid Profiling Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Cannabinoid Profiling Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Cannabinoid Profiling Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Cannabinoid Profiling Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Cannabinoid Profiling Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Cannabinoid Profiling Image Figure 2. Global Cannabinoid Profiling Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cannabinoid Profiling Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gas Chromatography Image Figure 5. Liquid Chromatography Image Figure 6. Global Cannabinoid Profiling Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cannabinoid Profiling Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cannabis Drug Manufacturers Image Figure 9. Cannabis Cultivators/Growers Image Figure 10. Research Institutes Image Figure 11. Others Image Figure 12. Global Cannabinoid Profiling Market Size (US$ Million) & (2021-2032) Figure 13. Global Cannabinoid Profiling Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cannabinoid Profiling Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cannabinoid Profiling Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cannabinoid Profiling Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cannabinoid Profiling Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cannabinoid Profiling Revenue Market Share by Type (2021-2032) Figure 20. Global Cannabinoid Profiling Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cannabinoid Profiling Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cannabinoid Profiling Revenue Market Share by Application (2021-2032) Figure 23. North America Cannabinoid Profiling Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cannabinoid Profiling Revenue Share by Type (2021-2032) Figure 25. North America Cannabinoid Profiling Revenue Share by Application (2021-2032) Figure 26. North America Cannabinoid Profiling Revenue Share by Country (2021-2032) Figure 27. United States Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cannabinoid Profiling Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cannabinoid Profiling Revenue Share by Type (2021-2032) Figure 32. Europe Cannabinoid Profiling Revenue Share by Application (2021-2032) Figure 33. Europe Cannabinoid Profiling Revenue Share by Country (2021-2032) Figure 34. Germany Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cannabinoid Profiling Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cannabinoid Profiling Revenue Share by Type (2021-2032) Figure 44. China Cannabinoid Profiling Revenue Share by Application (2021-2032) Figure 45. Asia Cannabinoid Profiling Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cannabinoid Profiling Revenue Share by Type (2021-2032) Figure 47. Asia Cannabinoid Profiling Revenue Share by Application (2021-2032) Figure 48. Asia Cannabinoid Profiling Revenue Share by Region (2021-2032) Figure 49. Japan Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cannabinoid Profiling Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cannabinoid Profiling Revenue Share by Type (2021-2032) Figure 57. SAMEA Cannabinoid Profiling Revenue Share by Application (2021-2032) Figure 58. SAMEA Cannabinoid Profiling Revenue Share by Country (2021-2032) Figure 59. Brazil Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cannabinoid Profiling Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Gas Chromatography
  • Liquid Chromatography
Applications
  • Cannabis Drug Manufacturers
  • Cannabis Cultivators/Growers
  • Research Institutes
  • Others
Companies covered
  • Saskatchewan Research Council (SRC)
  • SC Labs
  • Steep Hill
  • SGS Canada
  • CW ANALYTICAL
  • PharmLabs
  • GreenLeaf Lab
  • Kaycha Holdings
  • American Clinical Solutions
  • CannaSafe
  • Aurum Labs
  • A&L Canada Laboratories
  • Royalmount Laboratories
  • Confidence Analytics
  • ACT Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cannabinoid Profiling Market by Type
  3. 1.2.1 Global Cannabinoid Profiling Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gas Chromatography
  5. 1.2.3 Liquid Chromatography
  6. 1.3 Cannabinoid Profiling Market by Application
  7. 1.3.1 Global Cannabinoid Profiling Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cannabis Drug Manufacturers
  9. 1.3.3 Cannabis Cultivators/Growers
  10. 1.3.4 Research Institutes
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cannabinoid Profiling Market Dynamics
  1. 2.1 Cannabinoid Profiling Industry Trends
  2. 2.2 Cannabinoid Profiling Industry Drivers
  3. 2.3 Cannabinoid Profiling Industry Opportunities and Challenges
  4. 2.4 Cannabinoid Profiling Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cannabinoid Profiling Market Perspective (2021-2032)
  2. 3.2 Global Cannabinoid Profiling Growth Trends by Region
  3. 3.2.1 Global Cannabinoid Profiling Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cannabinoid Profiling Market Size by Region (2021-2026)
  5. 3.2.3 Global Cannabinoid Profiling Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cannabinoid Profiling Revenue by Players
  2. 4.1.1 Global Cannabinoid Profiling Revenue by Players (2021-2026)
  3. 4.1.2 Global Cannabinoid Profiling Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cannabinoid Profiling Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cannabinoid Profiling Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cannabinoid Profiling Key Players Headquarters & Area Served
  7. 4.4 Global Cannabinoid Profiling Players, Product Type & Application
  8. 4.5 Global Cannabinoid Profiling Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cannabinoid Profiling Market CR5 and HHI
  11. 4.6.3 2025 Cannabinoid Profiling Tier 1, Tier 2, and Tier 3
5 Cannabinoid Profiling Market Size by Type
  1. 5.1 Global Cannabinoid Profiling Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cannabinoid Profiling Revenue by Type (2021-2032)
  3. 5.3 Global Cannabinoid Profiling Revenue Market Share by Type (2021-2032)
6 Cannabinoid Profiling Market Size by Application
  1. 6.1 Global Cannabinoid Profiling Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cannabinoid Profiling Revenue by Application (2021-2032)
  3. 6.3 Global Cannabinoid Profiling Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Saskatchewan Research Council (SRC)
  2. 7.1.1 Saskatchewan Research Council (SRC) Company Information
  3. 7.1.2 Saskatchewan Research Council (SRC) Business Overview
  4. 7.1.3 Saskatchewan Research Council (SRC) Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Saskatchewan Research Council (SRC) Cannabinoid Profiling Product Portfolio
  6. 7.1.5 Saskatchewan Research Council (SRC) Recent Developments
  7. 7.2 SC Labs
  8. 7.2.1 SC Labs Company Information
  9. 7.2.2 SC Labs Business Overview
  10. 7.2.3 SC Labs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  11. 7.2.4 SC Labs Cannabinoid Profiling Product Portfolio
  12. 7.2.5 SC Labs Recent Developments
  13. 7.3 Steep Hill
  14. 7.3.1 Steep Hill Company Information
  15. 7.3.2 Steep Hill Business Overview
  16. 7.3.3 Steep Hill Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Steep Hill Cannabinoid Profiling Product Portfolio
  18. 7.3.5 Steep Hill Recent Developments
  19. 7.4 SGS Canada
  20. 7.4.1 SGS Canada Company Information
  21. 7.4.2 SGS Canada Business Overview
  22. 7.4.3 SGS Canada Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SGS Canada Cannabinoid Profiling Product Portfolio
  24. 7.4.5 SGS Canada Recent Developments
  25. 7.5 CW ANALYTICAL
  26. 7.5.1 CW ANALYTICAL Company Information
  27. 7.5.2 CW ANALYTICAL Business Overview
  28. 7.5.3 CW ANALYTICAL Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CW ANALYTICAL Cannabinoid Profiling Product Portfolio
  30. 7.5.5 CW ANALYTICAL Recent Developments
  31. 7.6 PharmLabs
  32. 7.6.1 PharmLabs Company Information
  33. 7.6.2 PharmLabs Business Overview
  34. 7.6.3 PharmLabs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PharmLabs Cannabinoid Profiling Product Portfolio
  36. 7.6.5 PharmLabs Recent Developments
  37. 7.7 GreenLeaf Lab
  38. 7.7.1 GreenLeaf Lab Company Information
  39. 7.7.2 GreenLeaf Lab Business Overview
  40. 7.7.3 GreenLeaf Lab Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GreenLeaf Lab Cannabinoid Profiling Product Portfolio
  42. 7.7.5 GreenLeaf Lab Recent Developments
  43. 7.8 Kaycha Holdings
  44. 7.8.1 Kaycha Holdings Company Information
  45. 7.8.2 Kaycha Holdings Business Overview
  46. 7.8.3 Kaycha Holdings Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Kaycha Holdings Cannabinoid Profiling Product Portfolio
  48. 7.8.5 Kaycha Holdings Recent Developments
  49. 7.9 American Clinical Solutions
  50. 7.9.1 American Clinical Solutions Company Information
  51. 7.9.2 American Clinical Solutions Business Overview
  52. 7.9.3 American Clinical Solutions Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  53. 7.9.4 American Clinical Solutions Cannabinoid Profiling Product Portfolio
  54. 7.9.5 American Clinical Solutions Recent Developments
  55. 7.10 CannaSafe
  56. 7.10.1 CannaSafe Company Information
  57. 7.10.2 CannaSafe Business Overview
  58. 7.10.3 CannaSafe Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CannaSafe Cannabinoid Profiling Product Portfolio
  60. 7.10.5 CannaSafe Recent Developments
  61. 7.11 Aurum Labs
  62. 7.11.1 Aurum Labs Company Information
  63. 7.11.2 Aurum Labs Business Overview
  64. 7.11.3 Aurum Labs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Aurum Labs Cannabinoid Profiling Product Portfolio
  66. 7.11.5 Aurum Labs Recent Developments
  67. 7.12 A&L Canada Laboratories
  68. 7.12.1 A&L Canada Laboratories Company Information
  69. 7.12.2 A&L Canada Laboratories Business Overview
  70. 7.12.3 A&L Canada Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  71. 7.12.4 A&L Canada Laboratories Cannabinoid Profiling Product Portfolio
  72. 7.12.5 A&L Canada Laboratories Recent Developments
  73. 7.13 Royalmount Laboratories
  74. 7.13.1 Royalmount Laboratories Company Information
  75. 7.13.2 Royalmount Laboratories Business Overview
  76. 7.13.3 Royalmount Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Royalmount Laboratories Cannabinoid Profiling Product Portfolio
  78. 7.13.5 Royalmount Laboratories Recent Developments
  79. 7.14 Confidence Analytics
  80. 7.14.1 Confidence Analytics Company Information
  81. 7.14.2 Confidence Analytics Business Overview
  82. 7.14.3 Confidence Analytics Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Confidence Analytics Cannabinoid Profiling Product Portfolio
  84. 7.14.5 Confidence Analytics Recent Developments
  85. 7.15 ACT Laboratories
  86. 7.15.1 ACT Laboratories Company Information
  87. 7.15.2 ACT Laboratories Business Overview
  88. 7.15.3 ACT Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  89. 7.15.4 ACT Laboratories Cannabinoid Profiling Product Portfolio
  90. 7.15.5 ACT Laboratories Recent Developments
8 North America
  1. 8.1 North America Cannabinoid Profiling Revenue (2021-2032)
  2. 8.2 North America Cannabinoid Profiling Revenue by Type (2021-2032)
  3. 8.2.1 North America Cannabinoid Profiling Revenue by Type (2021-2026)
  4. 8.2.2 North America Cannabinoid Profiling Revenue by Type (2027-2032)
  5. 8.3 North America Cannabinoid Profiling Revenue Share by Type (2021-2032)
  6. 8.4 North America Cannabinoid Profiling Revenue by Application (2021-2032)
  7. 8.4.1 North America Cannabinoid Profiling Revenue by Application (2021-2026)
  8. 8.4.2 North America Cannabinoid Profiling Revenue by Application (2027-2032)
  9. 8.5 North America Cannabinoid Profiling Revenue Share by Application (2021-2032)
  10. 8.6 North America Cannabinoid Profiling Revenue by Country
  11. 8.6.1 North America Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cannabinoid Profiling Revenue by Country (2021-2026)
  13. 8.6.3 North America Cannabinoid Profiling Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cannabinoid Profiling Revenue (2021-2032)
  2. 9.2 Europe Cannabinoid Profiling Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cannabinoid Profiling Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cannabinoid Profiling Revenue by Type (2027-2032)
  5. 9.3 Europe Cannabinoid Profiling Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cannabinoid Profiling Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cannabinoid Profiling Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cannabinoid Profiling Revenue by Application (2027-2032)
  9. 9.5 Europe Cannabinoid Profiling Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cannabinoid Profiling Revenue by Country
  11. 9.6.1 Europe Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cannabinoid Profiling Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cannabinoid Profiling Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cannabinoid Profiling Revenue (2021-2032)
  2. 10.2 China Cannabinoid Profiling Revenue by Type (2021-2032)
  3. 10.2.1 China Cannabinoid Profiling Revenue by Type (2021-2026)
  4. 10.2.2 China Cannabinoid Profiling Revenue by Type (2027-2032)
  5. 10.3 China Cannabinoid Profiling Revenue Share by Type (2021-2032)
  6. 10.4 China Cannabinoid Profiling Revenue by Application (2021-2032)
  7. 10.4.1 China Cannabinoid Profiling Revenue by Application (2021-2026)
  8. 10.4.2 China Cannabinoid Profiling Revenue by Application (2027-2032)
  9. 10.5 China Cannabinoid Profiling Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cannabinoid Profiling Revenue (2021-2032)
  2. 11.2 Asia Cannabinoid Profiling Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cannabinoid Profiling Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cannabinoid Profiling Revenue by Type (2027-2032)
  5. 11.3 Asia Cannabinoid Profiling Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cannabinoid Profiling Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cannabinoid Profiling Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cannabinoid Profiling Revenue by Application (2027-2032)
  9. 11.5 Asia Cannabinoid Profiling Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cannabinoid Profiling Revenue by Country
  11. 11.6.1 Asia Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cannabinoid Profiling Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cannabinoid Profiling Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cannabinoid Profiling Revenue (2021-2032)
  2. 12.2 SAMEA Cannabinoid Profiling Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cannabinoid Profiling Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cannabinoid Profiling Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cannabinoid Profiling Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cannabinoid Profiling Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cannabinoid Profiling Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cannabinoid Profiling Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cannabinoid Profiling Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cannabinoid Profiling Revenue by Country
  11. 12.6.1 SAMEA Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cannabinoid Profiling Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cannabinoid Profiling Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research